Mayo Clinic

Investment Portfolio & 13F Holdings Analysis

About

Mayo Clinic is an institutional investment manager that filed its latest Form 13F for 2024Q3, reporting 3 holdings worth $0.0 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR • 2024-09-30

SEC FilingSEC DataHachi Filing

Report Date: 2024-09-30
Filing Date: 2024-11-12
Total Holdings: 3
Total Value: 2901667
Accession Number: 0000912282-24-000766
Form Type: 13F-HR
CIK: 0001318153
Manager Name: Mayo Clinic

Data Enrichment

67% identified

2 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

3 positions • $2,901.667K total value

3 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Sort by:

464288257

17359(+0.0%)

Value:

$2.1B(+6.4%)

Zentalis Pharmaceuticals, Inc.

ZNTL|98943L107

175000(-6.5%)

Value:

$644.0M(-15.9%)

Unity Biotechnology, Inc.

UBX|91381U200

124081(+0.0%)

Value:

$182.4M(+8.9%)

Instrument	Shares		Other Manager	Value
(cusip464288257)✕	17.4K	QoQ 0.00% (+0) YoY-	All Managers (Combined)	$2.1M	QoQ +6.36% (+$124.1K) YoY-
Zentalis Pharmaceuticals, Inc.(ZNTLcusip98943L107)	175.0K	QoQ -6.48% (-12.1K) YoY-	All Managers (Combined)	$644.0K	QoQ -15.86% (-$121.4K) YoY-
Unity Biotechnology, Inc.(UBXcusip91381U200)	124.1K	QoQ 0.00% (+0) YoY-	All Managers (Combined)	$182.4K	QoQ +8.88% (+$14.9K) YoY-